Treatment or Diagnosis in Digital Medicine: Which Offers a More Viable Business Model

Join us for a thought-provoking discussion as we delve into the heart of this matter. During this meeting, we will explore the nuances of both approaches, considering factors such as market demand, regulatory considerations, technological advancements, and financial sustainability. Key discussion questions include:

• What are the current trends in consumer preferences and healthcare needs that could inform the decision between prioritising diagnosis or treatment?

• How do regulatory frameworks and approval processes differ for diagnostic tools versus digital treatment solutions, and how might these impact business viability?

• In terms of scalability and long-term sustainability, which model - diagnosis or treatment-focused - offers more promising prospects for investors and entrepreneurs?

• Considering technological advancements like AI and telemedicine, how might these innovations influence the feasibility and effectiveness of diagnostic and treatment-oriented digital solutions?